Jeff Yass’s Orphazyme A/S ORPH Stock Holding History

Jeff Yass’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-114,372	Closed	-$276K	–	14510
2021 Q4	$276K	Sell	114,372 -41,176	-26%	-$145K	﹤0.01%	10687
2021 Q3	$639K	Buy	155,548 +1,392	+0.9%	+$7.16K	﹤0.01%	8756
2021 Q2	$1.13M	Buy	+154,156	New	+$1.24M	﹤0.01%	7425

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Jeff Yass's ORPH Position: Q1 2022 in Review

Jeff Yass sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 114,372 shares — an estimated $276K sold.

Jeff Yass first reported a position in ORPH in Q2 2021 and held it in 3 quarters. The position peaked at $1.13M in Q2 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Jeff Yass reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Jeff Yass sold 114,372 Orphazyme A/S shares in Q1 2022, an estimated $276K.
Jeff Yass first reported a position in Orphazyme A/S in Q2 2021 and held it in 3 quarters.
Jeff Yass's Orphazyme A/S position peaked at $1.13M in Q2 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.